{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:56:44Z","timestamp":1781143004773,"version":"3.54.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["22K08823"],"award-info":[{"award-number":["22K08823"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48779-7","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T09:34:32Z","timestamp":1776591272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exosomal microRNA-4800-3p in portal vein blood promotes liver metastasis in pancreatic cancer by targeting PLAA"],"prefix":"10.1038","volume":"16","author":[{"given":"Satoru","family":"Miyahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Tomimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Iwagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisaku","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Akita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadafumi","family":"Asaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzo","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Morii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,19]]},"reference":[{"key":"48779_CR1","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","volume":"267","author":"VP Groot","year":"2018","unstructured":"Groot, V. P. et al. Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma. Ann. Surg. 267, 936\u2013945 (2018).","journal-title":"Ann. Surg."},{"key":"48779_CR2","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1245\/s10434-018-6558-7","volume":"25","author":"VP Groot","year":"2018","unstructured":"Groot, V. P. et al. Implications of the Pattern of Disease Recurrence on Survival Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma. Ann. Surg. Oncol. 25, 2475\u20132483 (2018).","journal-title":"Ann. Surg. Oncol."},{"key":"48779_CR3","doi-asserted-by":"publisher","first-page":"102103","DOI":"10.1016\/j.suronc.2024.102103","volume":"55","author":"S Miyahara","year":"2024","unstructured":"Miyahara, S. et al. Organ-specific variations in tumor marker dynamics in postoperative pancreatic cancer recurrence: Trends in lung and liver recurrence highlighting biological heterogeneity. Surg. Oncol. 55, 102103 (2024).","journal-title":"Surg. Oncol."},{"key":"48779_CR4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1186\/s12885-018-4679-9","volume":"18","author":"IH Sahin","year":"2018","unstructured":"Sahin, I. H., Elias, H., Chou, J. F. & Capanu, M. O\u2019Reilly, E. M. Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior. BMC Cancer. 18, 769 (2018).","journal-title":"BMC Cancer"},{"key":"48779_CR5","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1038\/s41467-023-41771-z","volume":"14","author":"SK Thomas","year":"2023","unstructured":"Thomas, S. K. et al. Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice. Nat. Commun. 14, 6330 (2023).","journal-title":"Nat. Commun."},{"key":"48779_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00535-018-1519-2","volume":"54","author":"M Kitano","year":"2019","unstructured":"Kitano, M. et al. Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer. J. Gastroenterol. 54, 19\u201332 (2019).","journal-title":"J. Gastroenterol."},{"key":"48779_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cancergen.2017.08.006","volume":"218\u2013219","author":"EE Vietsch","year":"2017","unstructured":"Vietsch, E. E. et al. Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer. Cancer Genet. 218\u2013219, 39\u201350 (2017).","journal-title":"Cancer Genet."},{"key":"48779_CR8","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.4251\/wjgo.v13.i10.1263","volume":"13","author":"S Perales","year":"2021","unstructured":"Perales, S. et al. Liquid biopsy approach to pancreatic cancer. World J. Gastrointest. Oncol. 13, 1263\u20131287 (2021).","journal-title":"World J. Gastrointest. Oncol."},{"key":"48779_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/jama.2013.284664","volume":"311","author":"NA Schultz","year":"2014","unstructured":"Schultz, N. A. et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA 311, 392\u2013404 (2014).","journal-title":"JAMA"},{"key":"48779_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-018-0897-7","volume":"17","author":"Z Sun","year":"2018","unstructured":"Sun, Z. et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol. Cancer. 17, 147 (2018).","journal-title":"Mol. Cancer"},{"key":"48779_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/annonc\/mdv604","volume":"27","author":"FA San Lucas","year":"2016","unstructured":"San Lucas, F. A. et al. Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes. Ann. Oncol. 27, 635\u2013641 (2016).","journal-title":"Ann. Oncol."},{"key":"48779_CR12","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.hpb.2019.11.003","volume":"22","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Yu, X., Hartmann, D. & Zhou, J. Circulating tumor cells in peripheral blood of pancreatic cancer patients and their prognostic role: a systematic review and meta-analysis. HPB (Oxford). 22, 660\u2013669 (2020).","journal-title":"HPB (Oxford)"},{"key":"48779_CR13","doi-asserted-by":"crossref","unstructured":"Grunvald, M. W., Jacobson, R. A., Kuzel, T. M., Pappas, S. G. & Masood, A. Current status of circulating tumor DNA liquid biopsy in pancreatic cancer. Int. J. Mol. Sci. 21 (2020).","DOI":"10.3390\/ijms21207651"},{"key":"48779_CR14","doi-asserted-by":"crossref","unstructured":"Tsai, K. Y. et al. Current applications and future directions of circulating tumor cells in colorectal cancer recurrence. Cancers (Basel) 16 (2024).","DOI":"10.3390\/cancers16132316"},{"key":"48779_CR15","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1001\/jamaoncol.2019.3616","volume":"5","author":"J Tie","year":"2019","unstructured":"Tie, J. et al. Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer. JAMA Oncol. 5, 1710\u20131717 (2019).","journal-title":"JAMA Oncol."},{"key":"48779_CR16","doi-asserted-by":"crossref","unstructured":"Xu, X., Bhandari, K., Xu, C., Morris, K. & Ding, W. Q. miR-18a and miR-106a signatures in plasma small EVs are promising biomarkers for early detection of pancreatic ductal adenocarcinoma. Int J. Mol. Sci 24 (2023).","DOI":"10.3390\/ijms24087215"},{"key":"48779_CR17","doi-asserted-by":"crossref","unstructured":"Nishiwada, S. et al. Transcriptomic profiling identifies an exosomal microRNA signature for predicting recurrence following surgery in patients with pancreatic ductal adenocarcinoma. Ann. Surg. (2021).","DOI":"10.1097\/SLA.0000000000004993"},{"key":"48779_CR18","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.3892\/or.2017.5919","volume":"38","author":"D Chen","year":"2017","unstructured":"Chen, D. et al. Upregulated exosomic miR\u201323b\u20133p plays regulatory roles in the progression of pancreatic cancer. Oncol. Rep. 38, 2182\u20132188 (2017).","journal-title":"Oncol. Rep."},{"key":"48779_CR19","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1159\/000495281","volume":"51","author":"Z Li","year":"2018","unstructured":"Li, Z. et al. Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer. Cell. Physiol. Biochem. 51, 610\u2013629 (2018).","journal-title":"Cell. Physiol. Biochem."},{"key":"48779_CR20","doi-asserted-by":"publisher","first-page":"42339","DOI":"10.1038\/srep42339","volume":"7","author":"M Mikamori","year":"2017","unstructured":"Mikamori, M. et al. MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma. Sci. Rep. 7, 42339 (2017).","journal-title":"Sci. Rep."},{"key":"48779_CR21","doi-asserted-by":"crossref","unstructured":"Ueda, H. et al. miR-6855-5p Enhances Radioresistance and promotes migration of pancreatic cancer by inducing epithelial-mesenchymal transition via suppressing FOXA1: Potential of plasma exosomal mir-6855-5p as an indicator of radiosensitivity in patients with pancreatic cancer. Ann. Surg. Oncol. (2024).","DOI":"10.1245\/s10434-024-16115-w"},{"key":"48779_CR22","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto, N. et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110\u20131122 (2014).","journal-title":"Cell"},{"key":"48779_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.eururo.2016.07.051","volume":"71","author":"NJ Vogelzang","year":"2017","unstructured":"Vogelzang, N. J. et al. Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer. Eur. Urol. 71, 168\u2013171 (2017).","journal-title":"Eur. Urol."},{"key":"48779_CR24","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/1878-0261.12537","volume":"13","author":"JS Lee","year":"2019","unstructured":"Lee, J. S., Park, S. S., Lee, Y. K., Norton, J. A. & Jeffrey, S. S. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA. Mol. Oncol. 13, 1623\u20131650 (2019).","journal-title":"Mol. Oncol."},{"key":"48779_CR25","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/bjc.2011.545","volume":"106","author":"L Khoja","year":"2012","unstructured":"Khoja, L. et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br. J. Cancer. 106, 508\u2013516 (2012).","journal-title":"Br. J. Cancer"},{"key":"48779_CR26","doi-asserted-by":"publisher","first-page":"224ra224","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda, C. et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl Med. 6, 224ra224 (2014).","journal-title":"Sci. Transl Med."},{"key":"48779_CR27","doi-asserted-by":"publisher","first-page":"632","DOI":"10.4251\/wjgo.v15.i4.632","volume":"15","author":"SW Ko","year":"2023","unstructured":"Ko, S. W. & Yoon, S. B. Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer. World J. Gastrointest. Oncol. 15, 632\u2013643 (2023).","journal-title":"World J. Gastrointest. Oncol."},{"key":"48779_CR28","first-page":"297","volume":"28","author":"H Iinuma","year":"2006","unstructured":"Iinuma, H. et al. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int. J. Oncol. 28, 297\u2013306 (2006).","journal-title":"Int. J. Oncol."},{"key":"48779_CR29","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.21037\/jgo-21-734","volume":"12","author":"X Zhao","year":"2021","unstructured":"Zhao, X. et al. Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients. J. Gastrointest. Oncol. 12, 3050\u20133060 (2021).","journal-title":"J. Gastrointest. Oncol."},{"key":"48779_CR30","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s13277-014-2716-0","volume":"36","author":"M Bissolati","year":"2015","unstructured":"Bissolati, M. et al. Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer. Tumour Biol. 36, 991\u2013996 (2015).","journal-title":"Tumour Biol."},{"key":"48779_CR31","doi-asserted-by":"crossref","unstructured":"Nitschke, C. et al. Peripheral and portal venous KRAS ctDNA detection as independent prognostic markers of early tumor recurrence in pancreatic ductal adenocarcinoma. Clin. Chem. (2023).","DOI":"10.1016\/j.pan.2023.06.687"},{"key":"48779_CR32","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1245\/s10434-020-09518-y","volume":"28","author":"MG White","year":"2021","unstructured":"White, M. G. et al. Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma. Ann. Surg. Oncol. 28, 4615\u20134622 (2021).","journal-title":"Ann. Surg. Oncol."},{"key":"48779_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/jhbp.601","volume":"26","author":"S Kawamura","year":"2019","unstructured":"Kawamura, S. et al. Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients. J. Hepatobiliary Pancreat. Sci. 26, 63\u201372 (2019).","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"48779_CR34","doi-asserted-by":"crossref","unstructured":"Agarwal, V., Bell, G. W. & Nam, J. W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 4 (2015).","DOI":"10.7554\/eLife.05005"},{"key":"48779_CR35","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1038\/s41388-022-02411-w","volume":"41","author":"Z Shen","year":"2022","unstructured":"Shen, Z. et al. PLAA suppresses ovarian cancer metastasis via METTL3-mediated m(6)A modification of TRPC3 mRNA. Oncogene 41, 4145\u20134158 (2022).","journal-title":"Oncogene"},{"key":"48779_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12957-022-02743-7","volume":"20","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Increased expression of METTL3 in pancreatic cancer tissues associates with poor survival of the patients. World J. Surg. Oncol. 20, 283 (2022).","journal-title":"World J. Surg. Oncol."},{"key":"48779_CR37","doi-asserted-by":"publisher","first-page":"101063","DOI":"10.1016\/j.drup.2024.101063","volume":"73","author":"X Ou","year":"2024","unstructured":"Ou, X. et al. Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer. Drug Resist. Updat. 73, 101063 (2024).","journal-title":"Drug Resist. Updat"},{"key":"48779_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature 527, 329\u2013335 (2015).","journal-title":"Nature"},{"key":"48779_CR39","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva, B. et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. Cell. Biol. 17, 816\u2013826 (2015).","journal-title":"Nat. Cell. Biol."},{"key":"48779_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11894-019-0733-2","volume":"21","author":"CG Chapman","year":"2019","unstructured":"Chapman, C. G. & Waxman, I. EUS-Guided Portal Venous Sampling of Circulating Tumor Cells. Curr. Gastroenterol. Rep. 21, 68 (2019).","journal-title":"Curr. Gastroenterol. Rep."},{"key":"48779_CR41","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13045-022-01348-7","volume":"15","author":"J Lin","year":"2022","unstructured":"Lin, J. et al. Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p\/BPTF axis and degrading BIN1. J. Hematol. Oncol. 15, 128 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"48779_CR42","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3892\/ol.2021.13080","volume":"22","author":"A Sueta","year":"2021","unstructured":"Sueta, A. et al. Exosomal miRNA profiles of triple-negative breast cancer in neoadjuvant treatment. Oncol. Lett. 22, 819 (2021).","journal-title":"Oncol. Lett."},{"key":"48779_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12920-017-0260-7","volume":"10","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Serum MicroRNA profile in patients with colon adenomas or cancer. BMC Med. Genomics. 10, 23 (2017).","journal-title":"BMC Med. Genomics"},{"key":"48779_CR44","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1128\/MCB.26.3.822-830.2006","volume":"26","author":"JE Mullally","year":"2006","unstructured":"Mullally, J. E., Chernova, T. & Wilkinson, K. D. Doa1 is a Cdc48 adapter that possesses a novel ubiquitin binding domain. Mol. Cell. Biol. 26, 822\u2013830 (2006).","journal-title":"Mol. Cell. Biol."},{"key":"48779_CR45","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.molcel.2010.10.018","volume":"40","author":"N Pashkova","year":"2010","unstructured":"Pashkova, N. et al. WD40 repeat propellers define a ubiquitin-binding domain that regulates turnover of F box proteins. Mol. Cell. 40, 433\u2013443 (2010).","journal-title":"Mol. Cell."},{"key":"48779_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","volume":"13","author":"C Zeng","year":"2020","unstructured":"Zeng, C., Huang, W., Li, Y. & Weng, H. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J. Hematol. Oncol. 13, 117 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"48779_CR47","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12943-019-1065-4","volume":"18","author":"B Yue","year":"2019","unstructured":"Yue, B. et al. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol. Cancer. 18, 142 (2019).","journal-title":"Mol. Cancer"},{"key":"48779_CR48","doi-asserted-by":"publisher","first-page":"110440","DOI":"10.1016\/j.cellsig.2022.110440","volume":"99","author":"Y Tang","year":"2022","unstructured":"Tang, Y., Gao, G., Xia, W. W. & Wang, J. B. METTL3 promotes the growth and metastasis of pancreatic cancer by regulating the m6A modification and stability of E2F5. Cell. Signal. 99, 110440 (2022).","journal-title":"Cell. Signal."},{"key":"48779_CR49","doi-asserted-by":"publisher","first-page":"e2294","DOI":"10.1038\/cddis.2016.169","volume":"7","author":"H Zhou","year":"2016","unstructured":"Zhou, H. et al. GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR. Cell. Death Dis. 7, e2294 (2016).","journal-title":"Cell. Death Dis."},{"key":"48779_CR50","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.7150\/jca.52578","volume":"12","author":"X Qian","year":"2021","unstructured":"Qian, X., Jiang, C., Shen, S. & Zou, X. GPRC5A: An emerging prognostic biomarker for predicting malignancy of Pancreatic Cancer based on bioinformatics analysis. J. Cancer. 12, 2010\u20132022 (2021).","journal-title":"J. Cancer"},{"key":"48779_CR51","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1158\/1078-0432.CCR-16-2656","volume":"23","author":"M Pierobon","year":"2017","unstructured":"Pierobon, M. et al. Enrichment of PI3K-AKT-mTOR Pathway activation in hepatic metastases from breast cancer. Clin. Cancer Res. 23, 4919\u20134928 (2017).","journal-title":"Clin. Cancer Res."},{"key":"48779_CR52","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ajpath.2014.10.014","volume":"185","author":"R Yuge","year":"2015","unstructured":"Yuge, R. et al. mTOR and PDGF pathway blockade inhibits liver metastasis of colorectal cancer by modulating the tumor microenvironment. Am. J. Pathol. 185, 399\u2013408 (2015).","journal-title":"Am. J. Pathol."},{"key":"48779_CR53","doi-asserted-by":"publisher","first-page":"e12186","DOI":"10.1002\/jev2.12186","volume":"11","author":"S Zhao","year":"2022","unstructured":"Zhao, S. et al. Highly-metastatic colorectal cancer cell released miR-181a-5p-rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment. J. Extracell. Vesicles. 11, e12186 (2022).","journal-title":"J. Extracell. Vesicles"},{"key":"48779_CR54","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/hep.32009","volume":"74","author":"H Sun","year":"2021","unstructured":"Sun, H. et al. Hypoxia-inducible exosomes facilitate liver-tropic premetastatic niche in colorectal cancer. Hepatology 74, 2633\u20132651 (2021).","journal-title":"Hepatology"},{"key":"48779_CR55","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1007\/s00268-017-4068-6","volume":"41","author":"B Zheng","year":"2017","unstructured":"Zheng, B. et al. Primary Recurrence in the Lung is Related to Favorable Prognosis in Patients with Pancreatic Cancer and Postoperative Recurrence. World J. Surg. 41, 2858\u20132866 (2017).","journal-title":"World J. Surg."},{"key":"48779_CR56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/SLA.0b013e31823d813c","volume":"255","author":"H Takahashi","year":"2012","unstructured":"Takahashi, H. et al. Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer. Ann. Surg. 255, 95\u2013102 (2012).","journal-title":"Ann. Surg."},{"key":"48779_CR57","doi-asserted-by":"crossref","unstructured":"Schageman, J. et al. The complete exosome workflow solution: from isolation to characterization of RNA cargo. Biomed. Res. Int. 253957 2013 (2013).","DOI":"10.1155\/2013\/253957"},{"key":"48779_CR58","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/cas.14807","volume":"112","author":"Y Yokota","year":"2021","unstructured":"Yokota, Y. et al. Serum exosomal miR-638 is a prognostic marker of HCC via downregulation of VE-cadherin and ZO-1 of endothelial cells. Cancer Sci. 112, 1275\u20131288 (2021).","journal-title":"Cancer Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48779-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48779-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48779-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:02:00Z","timestamp":1781139720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48779-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,19]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48779"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48779-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,19]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SK received honoraria and speaker fees from Taiho Pharmaceutical Co., Ltd. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18151"}}